Cite

HARVARD Citation

    Sun, F. et al. (n.d.). PO-1204 Adjuvant immunotherapy after concurrent chemoradiotherapy for stage 3 NSCLC, outcomes from a large cancer centre. Radiotherapy and oncology. pp. S999-S1000. [Online]. 
  
Back to record